Ana Maria Sandri - Concepedia

Author

Ana Maria Sandri

Pontifícia Universidade Católica do Rio Grande do Sul

Also Known As

A SANDRI, A Sandri, A. M. Sandri, A.M. Sandri, Ana Elias, Ana M. Sandri, Ana Maria Sandri

Publications

809

Citations

H-Index

Concepts

All Affiliations

Pontifícia Universidade Católica do Rio Grande do Sul Monash University Universidade Federal do Rio Grande do Sul Australian Regenerative Medicine Institute New York Hospital Queens

About

Ana Maria Sandri is an author at Pontifícia Universidade Católica do Rio Grande do Sul specializing in medicine, health sciences, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	181
2	Health Sciences	3	3	160
3	Microbiology	2	2	54
4	Law	1	1	16
5	Hospital Medicine	1	1	106

Ana Maria Sandri

Publications

703

Citations

H-Index

Page 1

	Year	Citations
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob, Clinical Infectious Diseases	2013	417
Reduction in Inddence of Nosocomial Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA Ana Maria Sandri, Micheline Gisele Dalarosa, Luciana Ruschel de Alcântara, Infection Control and Hospital Epidemiology Nasal CarrierDrug ResistanceHospital MedicineIntensive Care UnitAntimicrobial Stewardship	2006	106
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob, Journal of Antimicrobial Chemotherapy	2012	74
Outbreak of Carbapenem-Resistant <i>Providencia stuartii</i> in an Intensive Care Unit Alexandre Prehn Zavascki, Cecília G Carvalhaes, Geórgia L. da Silva, Infection Control and Hospital Epidemiology Bacterial ResistanceMedical MicrobiologyAntimicrobial SusceptibilityIntensive Care UnitAntimicrobial Stewardship	2012	38
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients Patrick O. Hanafin, Roger L. Nation, Marc H. Scheetz, CPT Pharmacometrics & Systems Pharmacology	2021	31
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients Patrick O. Hanafin, Andrea Lay‐Hoon Kwa, Alexandre Prehn Zavascki, Clinical Microbiology and Infection Precision DosingPopulation Pharmacokinetic ModelPharmacologyPharmacotherapyProspective Clinical Data	2023	21
Usefulness of Escherichia coli and Enterobacteriaceae as Process Hygiene Criteria in poultry: experimental study Veronica Cibin, Marzia Mancin, Karl Pedersen, EFSA Supporting Publications Novel FoodEuropean LawEscherichia ColiLawProcess Hygiene Criteria	2014	16

Page 1